ASMB · NASDAQ · Biotechnology

Assembly Biosciences (ASMB)

Develops antiviral and liver-disease candidates through discovery and clinical development.

$25.70
vs last close+0.26 (+1.03%)
  1. Best Momentum Stocks to Buy for September 17th

    Zacks Investment Research

  2. New Strong Buy Stocks for September 17th

    Zacks Investment Research